Zobrazeno 1 - 10
of 110
pro vyhledávání: '"Papoutselis M"'
Autor:
Stamatiou, I., Misidou, C., Panagiotopoulos, Ε., Vrachiolias, G., Malkoc, B., Inglezou, L., Kolovos, P., Roubakis, C., Pentidou, A., Papoutselis, M., Bezirgiannidou, Z., Spanoudakis, E., Kotsianidis, I., Liapis, K.
Publikováno v:
Archives of Hellenic Medicine / Arheia Ellenikes Iatrikes; Jul/Aug2024, Vol. 41 Issue 4, p570-572, 3p
Autor:
Kotsianidis, I., Hatzimichael, E., Pappa, V., Galanopoulos, A., Kourakli, A., Diamantopoulos, P., Papageorgiou, S., Liapis, K., Papadopoulos, V., Papoutselis, M., Bouchla, A., Georgoulis, V., Vassilakopoulos, T., Solomou, E., Dimou, M., Vassilopoulos, G., Vardi, A., Papaioannou, M., Pontikoglou, C., Anagnostopoulos, A., Panayiotidis, P., Kontopidou, F., Harchalakis, N., Adamopoulos, N., Ximeri, M., Zikos, P., Megalakaki, A., Repousis, P., Kotsopoulou, M., Dryllis, G., Tsoukanas, D., Kyrtsonis, M.-C., Poulakidas, E., Bouronikou, E., Delimpasis, S., Mparmparousi, D., Papadaki, H., Vyniou, N.A., Symeonidis, A.
Publikováno v:
In Leukemia Research May 2023 128 Supplement
Autor:
Dimitriou, D., Lamprianidou, E., Tasis, A., Kymbaridou, C., Spiropoulos, T., Rimpa, C.M., Papoutselis, M., Vrachiolias, G., Misidou, C., Papadakis, S., Liapis, K., Mitroulis, I., Kotsianidis, I.
Publikováno v:
In Leukemia Research May 2023 128 Supplement
Autor:
Misidou, C., Gkolia, E., Kymbaridou, C., Papadopoulos, V., Papoutselis, M., Liapis, K., Vrachiolias, G., Defteraios, S., Stakos, D., Kotsianidis, I.
Publikováno v:
In Leukemia Research May 2023 128 Supplement
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Panagiotopoulos, E., Misidou, C., Chatziantoniou, M., Malkoc, B., Inglezou, L., Papadakis, S., Kolovos, P., Stamatiou, I., Vrachiolias, G., Satiridou, E., Touzlantzi, D., Frigkas, K., Roubakis, C., Pentidou, A., Papoutselis, M., Bezirgiannidou, Z., Spanoudakis, E., Kotsianidis, I., Anagnostopoulos, N., Liapis, K.
Publikováno v:
Archives of Hellenic Medicine / Arheia Ellenikes Iatrikes; Jul/Aug2023, Vol. 40 Issue 4, p572-574, 3p
Background: 5-azacytidine (5-AZA) improves survival of patients with higher-risk myelodysplastic syndromes (MDSs) and oligoblastic acute myeloid leukemia (AML); however, predictive factors for response and outcome have not been consistently studied.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::2f1346cbba3a388fdd0c272409f84d91
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3104904
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3104904
Background: Hypomethylating agents have altered the prognosis of myelodysplastic syndrome (MDS) so that long-term survival is now a feasible treatment goal. Patients and Methods: We analyzed data from patients with MDS treated with 5-azacytidine reco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::9769b866e314facc62de343ca9b5b9f0
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3078653
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3078653
Higher-risk Myelodysplastic syndromes (MDS) patients undergoing treatment with 5-azacytidine (AZA) are typically elderly with several comorbidities. However, the effect of comorbidities on the effectiveness and safety of AZA in real-world settings re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::ca0c7e0bcadf9cf7dcd2d4a67fd80dee
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3078476
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3078476